J. Jacobsen

Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept

Benjamin D. Sachs, M. Caron, J. Snyder, 2019, Neuropsychopharmacology.

Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat

A. Mørk, J. Jacobsen, 2006, Brain Research.

Selective cognitive deficits and reduced hippocampal brain-derived neurotrophic factor mRNA expression in small-conductance calcium-activated K+ channel deficient mice

J. Adelman, J. Mikkelsen, N. Mirza, 2009, Neuroscience.

Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan

E. Nielsen, N. Mirza, P. Weikop, 2008, Psychopharmacology.

SK3 K+ channel‐deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors

J. Adelman, P. Christophersen, J. Mikkelsen, 2008, Genes, brain, and behavior.

The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels

A. Mørk, J. Jacobsen, 2004, Brain Research.

Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept

Benjamin D. Sachs, M. Caron, J. Snyder, 2019, Neuropsychopharmacology.